Mantle Therapeutics
PrivateLast Round
Seed
Nov 26, 2024
Total Funding Raised
$3.5M
Company Overview
Mantle Therapeutics is a biotechnology company that develops treatments for rare fatal diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mantle Therapeutics Comparables
Compare Mantle Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Genevation LTD | 85% | |
| Nouscom | 79% | |
| Valo Therapeutics | 75% |
Mantle Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 26, 2024 |
Mantle Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RTW Investments | Seed |
| AIN Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 26, 2024
$4M round led by RTW Investments and AIN Ventures.
Mantle Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Mantle Therapeutics's valuation, stock price, and market status.
Is Mantle Therapeutics a public or private company?
Mantle Therapeutics is a private company.
What is the current stock price of Mantle Therapeutics?
Mantle Therapeutics is a private company with no public stock price. Caplight tracks Mantle Therapeutics's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Mantle Therapeutics worth (valuation)?
Valuation information for Mantle Therapeutics is not publicly available.
Can I buy Mantle Therapeutics stock?
Mantle Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Mantle Therapeutics's last funding round?
Mantle Therapeutics's most recent funding round was Seed on November 26, 2024.
Who are the main investors in Mantle Therapeutics?
Key investors in Mantle Therapeutics include RTW Investments, AIN Ventures.
Will Mantle Therapeutics IPO soon?
No public IPO plans have been announced for Mantle Therapeutics.
How can I track Mantle Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Mantle Therapeutics's secondary market activity and sign up for updates.